baber/WOPTO huggingface dataset:
Patent JP-3120083-B2 (JP)
IPC: H02K23/44
Filed: 1986-12-18
Granted: 2000-12-25
Abstract: There is described a rotor (14) for an electrical machine, the rotor having a current-carrying winding comprising a plurality of circumferentially distributed winding portions which lie in at least one plane (A-D) perpendicular to the rotor axis (16), and extend from a radially inner region to a radially outer region. A commutator is provided by surfaces of the winding portions at the inner region, and the winding is formed from a plurality of conductive sections, each having ends which lie at said outer region, interconnections between the winding sections being made only by way of those ends. Thus, soldered connections made between the winding sections will be remote from the commutator, which is the main source of heat for overheating, and moreover will be at positions where air cooling due to rotor movement is greatest. Air gaps between the winding portions at the outer region aid this cooling affect even further.
Patent JP-H0633268-B2 (JP)
IPC: C07D491/22
Filed: 1988-12-01
Abstract: Compounds of formula (I) : <CHEM> wherein X is hydroxy, hydrogen, cyano, -CH2NH2, or formyl; R is hydrogen when X is cyano, CH2NH2 or formyl, or R is -CHO or -CH2R<1> when X is hydrogen or hydroxy; R<1> is -O-R<2>; -S-R<2>; -N-R<2>(R<3>); or -N<+>-R<2>(R<3>)(R<4>), R<2>, R<3> and R<4> are the same or different and are selected from H, C1-6 alkyl, C2-6 hydroxyalkyl, C1-6 dialkylamino, C1-6-dialkylaminoC2-6 alkyl, C1-6 alkylamino-C2-6 alkyl, C2-6 aminoalkyl or a 3-7 member unsubstituted or substituted carbocyclic ring; and when R<1> is -N-R<2>(R<3>), the R<2> and R<3> groups may be combined together to form a ring and pharmaceutically acceptable salts, hydrate and solvates thereof, processes for their preparation, intermediates used in their preparation, pharmaceutical compositions containing them and their use in therapy as inhibitors of tumor cell growth.
Patent JP-3287793-B2 (JP)
IPC: A61K31/445
Filed: 1997-11-17
Granted: 2002-06-04
Abstract: The use of a compound of the formula (I):- <CHEM>  wherein     A is CH2 or NR in which R is H or C1-C6 alkyl;   B,D,E are each CH or N;   Y, Z<1> and G are certain stated substituents:  and e is 0, 1 or 2; for the manufacture of a medicament for treating atherosclerosis.
Patent JP-3827837-B2 (JP)
IPC: B60W30/02
Filed: 1997-11-19
Granted: 2006-09-27
Abstract: PROBLEM TO BE SOLVED: To quickly properly judge generation of an unstable behavior in the future of a vehicle by simple calculation, properly suppress this unstable behavior, and stabilize the vehicle behavior. SOLUTION: In a control device 30, a wheel speed, handle angle, actual yaw rate, and a cross acceleration are input, a car speed in a car speed calculation part 31, slip angle in a slip angle estimating part 32, and a road surface friction coefficient in a road surface friction coefficient estimation part 33, are obtained. The actual yaw rate, slip angle by a yawing energy calculation part 34, based on the road surface friction coefficient, dynamic energy in a rotational direction of a vehicle is calculated as yawing energy. A reference value preset in a decision value arithmetic part 35 is corrected in accordance with the road surface friction coefficient, the judging value is calculated. In a judging part 36, in the case of yawing energy exceeding the judging value, the vehicle is judged in an unstable condition.  In a drive control part 37, when the vehicle is placed in an unstable condition, based on the yawing energy and the judging value, target yaw moment is calculated, a brake drive part is actuated, a turn outer side front wheel is braked.
Patent JP-3132112-B2 (JP)
IPC: H04W60/00
Filed: 1991-12-25
Granted: 2001-02-05
Abstract: PURPOSE:To provide an incoming call method which requires no pager terminal even if it is considered that a simple portable telephone is unified with a pager terminal in a method where the portable telephone is called via a paging system is order to facilitate the incoming call through the portable telephone. CONSTITUTION:The position of a portable telephone terminal 16 is registered in a position register memory 8 of a radio base station 2 that received the radio waves by a position register request given from the terminal 16. In an incoming call state, the number of the terminal 16 is informed to each radio base station from a paging transmitter station 15. Then the station 2 storing the terminal number and the radio base stations 1 and 3 near the station 2 which received the information of the terminal from the station 2 call the terminal 16 for incoming call. Thus the terminal 16 is called by plural radio base stations and therefore the incoming call is possible even if the terminal 16 moves in a wider range. Then it is not required to previously connect another pager terminal to the terminal 16.
Patent JP-3650258-B2 (JP)
IPC: A61K31/085
Filed: 1997-12-24
Granted: 2005-05-18
Abstract: Disclosed is the use of cloprostenol, fluprostenol, their analogues and their pharmaceutically acceptable salts and esters for the treatment of glaucoma and ocular hypertension. Also disclosed are ophthalmic compositions comprising said compounds.
Patent JP-2865422-B2 (JP)
IPC: A61N1/30
Filed: 1990-10-23
Granted: 1999-03-08
Abstract: An iontophoresis device comprising a drug reservoir containing the drug in ionic form and in communication with the skin, a skin permeation enhancing agent contained in the reservoir or in a second reservoir also in communication with the skin, an electrode in contact with the drug, another electrode in contact with the skin, a D.C. power source connected to the electrodes and an electrically sensitive membrane interposed between the reservoir and the skin that is impermeable to drug in the absence of a voltage difference between the electrodes and permeable to the drug in the presence of a voltage difference. The skin permeation enhancing agent eliminates the skin as a rate-controlling element, thus making the rate of drug administration dependent upon the membrane permeability, which in turn is controlled electrically.
Patent JP-2594347-B2 (JP)
IPC: C10M141/10
Filed: 1988-01-06
Granted: 1997-03-26
Abstract: Gear oil compositions are described which comprise a lubricating base oil having dissolved therein:     (A) at least one phosphite ester characterized by the formula: <CHEM> wherein R<1> and R<2> are hydrocarbyl based groups of from 1 to 30 carbon atoms and   (B) at least one metal overbased composition. Another embodiment of the invention comprises the above-mentioned (A) and (B) with (C) a sulfurization product of an aliphatic olefinic compound containing from 3 to 30 carbon atoms. a
Patent JP-2868619-B2 (JP)
IPC: E05D7/10
Filed: 1993-06-09
Granted: 1999-03-10
Abstract: PCT No. PCT/EP93/01472 Sec. 371 Date Dec. 7, 1994 Sec. 102(e) Date Dec. 7, 1994 PCT Filed Jun. 9, 1993 PCT Pub. No. WO93/25790 PCT Pub. Date Dec. 23, 1993The invention concerns a hinge, in particular a hinge for switch-cabinet and instrument-cabinet doors, the hinge comprising a part fitted to the door and a part fitted to the cabinet which engage with each other for rotational motion by means of at least one hinge pin. In order to ensure that the hinge parts can be separated and reassembled rapidly and simply, the invention calls for at least one hinge part (10, 40) to be designed in two elements, via a first and a second element (11, 12; 41, 42) and that the first and second element (11, 12; 41, 42) can be displaced relative to each other in the longitudinal direction to enable the other part (20; 50) to be inserted and withdrawn again.
Patent JP-H0256282-B2 (JP)
IPC: C01B39/06
Filed: 1984-06-27
Abstract: The instant process relates to a process for treating zeolitic aluminosilicates which contain insoluble fluoride compounds by the use of soluble aluminum compounds.
Patent JP-3673281-B2 (JP)
IPC: A61K39/00
Filed: 1996-06-12
Granted: 2005-07-20
Abstract: The present invention concerns fibroblast growth factor receptor 3 (FGFR3) as a novel marker for mesenchymal skeletal progenitor cells. By utilizing this novel marker it was possible both to identify and locate mesenchymal skeletal progenitor cells in a tissue, as well as to obtain a substantially pure culture of such cells. The pure culture of the mesenchymal skeletal progenitor cells may be used, optionally after various manipulations ex vivo, as an active ingredient in pharmaceutical compositions or implants for the purpose of bone and/or cartilage repair. FGFR3 may also be used as a marker for the identification and the localization of cartilage- and bone-derived tumors. Agents capable of binding to FGFR3 may also be used for targeting cytotoxic agents to cartillage- and bone-derived tumors.The present invention concerns fibroblast growth factor receptor 3 (FGFR3) as a novel marker for mesenchymal skeletal progenitor cells. By utilizing this novel marker it was possible both to identify and locate mesenchymal skeletal progenitor cells in a tissue, as well as to obtain a substantially pure culture of such cells. The pure culture of the mesenchymal skeletal progenitor cells may be used, optionally after various manipulations ex vivo, as an active ingredient in pharmaceutical compositions or implants for the purpose of bone and/or cartilage repair. FGFR3 may also be used as a marker for the identification and the localization of cartilage- and bone-derived tumors. Agents capable of binding to FGFR3 may also be used for targeting cytotoxic agents to cartillage- and bone-derived tumors.
Patent JP-4231557-B2 (JP)
IPC: B26B21/00
Filed: 1998-06-19
Granted: 2009-03-04
Abstract: The invention concerns both a method and device for cutting hair. The device includes a multi-faceted cutting means (10) and a handle (20). The cutting means (10) is preferably formed from a broken piece of glass, preferably having a ragged broken edge to form a multi-faceted cutter with a plurality of cutting edges (13) distributed across it. Having cutting edges (13) distributed in this way, has been found to advantageously provide hair styling effects which give good texture to a hair cut and provide natural build.
Patent JP-3068187-B2 (JP)
IPC: A61M37/00
Filed: 1991-12-11
Granted: 2000-07-24
Abstract: Testosterone is administered transdermally through nonscrotal skin in a manner that mimics in amount and profile the natural production of testosterone in young adult healthy males. The testosterone is administered to the skin from a matrix which contains testosterone at subsaturation concentration and a permeation enhancer.
Patent JP-2595079-B2 (JP)
IPC: B23B27/04
Filed: 1988-08-08
Granted: 1997-03-26
Abstract: PCT No. PCT/SE88/00399 Sec. 371 Date Jan. 11, 1990 Sec. 102(e) Date Jan. 11, 1990 PCT Filed Aug. 8, 1988 PCT Pub. No. WO89/01375 PCT Pub. Date Feb. 23, 1989.A cutting insert, especially for turning tools, comprising an insert body having a transverse front cutting edge portion and a rear portion for mounting on and clamping to an insert holder, a cutting surface which connects with said cutting edge being provided with a central chip-forming recess. The novelty of the invention resides in that the chip-forming recess has a concave bottom surface which connects with the transverse cutting edge and with the rest of the cutting surface at a distance from said cutting edge, and that said recess is laterally restricted by inclined, convex sides having a curvature and shape relative to the concave bottom surface such that the bottom surface width at first decreases, as seen in the direction away from the cutting edge and backwards, and then increases again.
Patent JP-3884069-B2 (JP)
IPC: A23K1/18
Filed: 1995-07-21
Granted: 2007-02-21
Abstract: A method of transferring gut peptide antibodies to an animal in order to modulate feeding behaviour which method comprises: feeding to said animal a substance containing antibodies specific to a gut peptide wherein said substance is derived from a producer animal which has been immunized with a gut peptide.
Patent JP-2927956-B2 (JP)
IPC: A61K9/22
Filed: 1991-03-28
Granted: 1999-07-28
Abstract: An osmotic system is disclosed for delivering a beneficial agent formulation to an environment of use. The osmotic system comprises (a) an outside semipermeable wall, (b) a middle osmotically active layer, (c) a capsule comprising a beneficial agent, and (d) a passageway for dispensing the beneficial agent from the osmotic system.
Patent JP-2892159-B2 (JP)
IPC: H04N5/76
Filed: 1994-10-13
Granted: 1999-05-17
Abstract: A system (41) for playing a selected one of multiple audio tracks recorded in synchronized fashion with a motion picture on an optical disk (23). The optical disk (23) has encoded on it a mixing master music and effects ("M&E") track, or a switching master M&E track. Individual audio tracks are provided for language-specific versions of the same motion picture, but these tracks have data recorded in them only where there is dialog. In this way, for many a motion picture, all tracks but masters will have data recorded for well less than half of the running time of the motion picture. When a mixing master is used, it is mixed with a language-specific track when the latter has dialog the mixing master contains no dialog. If a switching master is used, it may contain dialog recorded with the M&E when a language-specific track has dialog recorded in it, it also contains M&E and the track is played to the exclusion of the switching master.
Patent JP-3740664-B2 (JP)
IPC: A61K35/18
Filed: 1995-10-12
Granted: 2006-02-01
Abstract: A flow through apparatus for implanting molecules into living blood cells of a patient, comprises a housing including an elongated flow through chamber having an inlet and an outlet at opposite ends thereof, a pair of elongated spaced apart parallel electrodes disposed between the inlet and the outlet for fluid to flow therebetween, a continuous flow shunt including a pump for withdrawing blood from a patient, passing it through the flow through chamber between the electrodes and returning it to the patient, apparatus for injecting a predetermined quantity of fluid medium carrying preselected molecules into the blood after it has been drawn from the patient and before it passes through said chamber, and an electrical source for applying a predetermined electric signal of a predetermined amplitude and duration to the electrodes for generating and repeatedly applying electric fields of a predetermined amplitude and duration to the flow of the mixture of blood and fluid medium in order to make the walls of preselected cells in the blood transiently permeable to permit molecules to enter the preselected cells without killing the cells.
Patent JP-3602135-B2 (JP)
IPC: C07K16/06
Filed: 1995-11-02
Granted: 2004-12-15
Abstract: PCT No. PCT/EP95/04307 Sec. 371 Date Apr. 24, 1997 Sec. 102(e) Date Apr. 24, 1997 PCT Filed Nov. 2, 1995 PCT Pub. No. WO96/14337 PCT Pub. Date May 17, 1996The invention concerns a composition composed of several different antibodies or/and antibody fragments which is suitable as a reagent to reduce interferences in an immunological method for the class-specific detection of antibodies from one or several of the immunoglobulin classes G, M, A, D and E.
Patent JP-3401256-B2 (JP)
IPC: B05B15/06
Filed: 1994-01-06
Granted: 2003-04-28
Abstract: A system for diluting and dispensing concentrated liquid products is disclosed. The system includes a dispensing device (10, 150) containing a removable proportioning means such as an aspirator assembly (40, 154). A concentrate pickup tube (114) attaches to the dispensing device and is in fluid communication with the aspirator assembly. The dispensing device can utilize a rigid outlet tube (20, 159) which is removably attached to nozzle tip (18, 158) for dispensing to large containers. Also disclosed is a method for diluting and dispensing chemical solutions using the dispensing device of the invention.
Patent JP-4375811-B2 (JP)
IPC: G02B1/10
Filed: 1995-12-27
Granted: 2009-12-02
Abstract: PCT No. PCT/CH95/00309 Sec. 371 Date Sep. 12, 1997 Sec. 102(e) Date Sep. 12, 1997 PCT Filed Dec. 27, 1995 PCT Pub. No. WO96/21167 PCT Pub. Date Jul. 11, 1996The invention relates to crosslinked polymers, which are polymerisation products of a polymerisable mixture that comprises the following components: a) a macromer of formula C  wherein Macro is an m-valent radical of a macromer from which the number m of groups Rxx-H has been removed, each Rx, independently of the others, is a bond, -O-, -NRN- or -S- wherein RN is hydrogen or lower alkyl, PI* is a bivalent radical of a photoinitiator, Raa is the moiety of a photoinitiator that forms the less reactive free radical on cleavage of the photoinitiator, and m is an integer from 1 to 100, b) a copolymerisable vinyl monomer and c) a copolymerisable crosslinker. The polymers are suitable especially for the production of mouldings, such as for contact lenses.
Patent JP-2989270-B2 (JP)
IPC: B22D11/115
Filed: 1995-10-16
Granted: 1999-12-13
Abstract: Flow control apparatus for enhancing inclusion float out in a continuous caster tundish comprising a dam positioned downstream from an impact pad and an energy source positioned between the dam and the exit nozzle of the tundish. The dam receives an incoming flood of molten metal released from the impact pad and redirects the flood of molten metal into multiple sub-flow currents which carry entrained inclusions toward a slag cover on the surface of the molten metal bath to enhance inclusion float out. The energy source provides means to restore kinetic energy to the sub-flow currents and increase the number of passes below the slag cover, thereby further enhancing inclusion float out.
Patent JP-3519407-B2 (JP)
IPC: A61K48/00
Filed: 1994-04-06
Granted: 2004-04-12
Abstract: PCT No. PCT/EP94/01065 Sec. 371 Date Sep. 29, 1995 Sec. 102(e) Date Sep. 29, 1995 PCT Filed Apr. 6, 1994 PCT Pub. No. WO94/24299 PCT Pub. Date Oct. 27, 1994Viruses or cells are targeted for selective internalization into a target in vive. A molecule Specific for a receptor on the surface of the target cell is introduced onto the surface of the virus or cell. The modified virus or cell binds the receptor in vive and is internalized by the target cell. The method provides vectors for selective delivery of nucleic acids to specific cell types in vivo and a means to alter the tropism of an infectious agent.
Patent JP-4338781-B2 (JP)
IPC: A61K35/768
Filed: 1994-04-29
Granted: 2009-10-07
Abstract: The invention provides compositions for treating cancer in a mammal comprising an effective amount of a Newcastle Disease Virus. The invention also provides a composition for treating cancer in a mammal comprising a Newcastle Disease Virus in combination with another agent such as a chemotherapeutic compound, a cytokine, an immunosuppressive agent, or an antibody.
Patent JP-3989546-B2 (JP)
IPC: B01J27/10
Filed: 1997-01-10
Granted: 2007-10-10
Abstract: An alkylation catalyst including a least one porous refractory metal oxide with at least one halogen on the surface thereof. The catalyst contains 0.005-1 wt % of at least one metal from groups IA and IIA of the periodic table of the elements and is particularly useful in an isobutane alkylation method using light olefins.
Patent JP-3578219-B2 (JP)
IPC: E04C5/12
Filed: 1995-04-13
Granted: 2004-10-20
Abstract: PCT No. PCT/CH95/00080 Sec. 371 Date Mar. 19, 1996 Sec. 102(e) Date Mar. 19, 1996 PCT Filed Apr. 13, 1995 PCT Pub. No. WO95/29308 PCT Pub. Date Nov. 2, 1995A conical anchoring system to anchor one or more loaded, stressed or pre-stressed tension elements (9) comprising a conical anchoring casing and an anchor body (7) fitting into the casing and retaining the tension element(s). The boundary surface between the anchor body and the casing wall is substantially designed to allow free sliding. To prevent the tension elements from being torn out of the anchor body or rupturing the anchor body itself, the rigidity of the gradient material forming the anchor body increases from the site of entry of the tension element at the cone, that is from the front zone, to the rear part of the anchor cone. Substantially improved shear distribution along the surface of the tension element(s) is achieved thereby over the case of substantially uniform rigidity of the anchor body.
Patent JP-3976794-B2 (JP)
IPC: A61F6/04
Filed: 1998-03-06
Granted: 2007-09-19
Abstract: A condom includes a condom tubular side wall having a first side wall end and a second side wall end, the tubular side wall being rolled outwardly and over itself from the second side wall end toward the first side wall end to form a side wall roll; a condom end wall sealingly joined to the tubular side wall at the first side wall end; and at least one strip of flexible material having a gripping tab end segment with a touch distinctive tactile surface on one side thereof, the at least one strip being wound within the side wall roll so that the gripping tab end segment and touch distinctive tactile surface of the at least one strip protrudes from the side wall roll. A method of assembling the condom includes the step of winding the at least one strip together with the tubular side wall outwardly and over the tubular side wall toward the side wall second end to form a side wall roll, so that the gripping tab end segment protrudes from the side wall roll. A method of applying the condom to a penis includes the steps of grasping the tab end segment, touching the touch distinctive tactile surface thereon, orienting the condom so that the tubular side wall roll is directed away from the user, placing the condom end wall against the distal end of the penis, and pulling the tab end segment laterally outwardly from the tubular side wall, so that the side wall roll unrolls over and advances longitudinally along the penis.
Patent JP-4491076-B2 (JP)
IPC: C23C8/10
Filed: 1998-03-27
Granted: 2010-06-30
Abstract: A coating of blue-black or black oxidized zirconium of uniform and controlled thickness on a zirconium or zirconium alloy material is accomplished through the use of a single phase crystalline material substrate having an altered surface roughness. An oxidized zirconium coating of uniform and controlled thickness is especially useful on orthopedic implants of zirconium or zirconium-based alloys to provide low friction, highly wear resistant surfaces on artificial joints, such as, but not limited to, hip joints, knee joints, shoulders, elbows, and spinal implants. The uniformly thick oxidized zirconium surface of controlled depth on prostheses provide a barrier against implant corrosion caused by ionization of the metal prostheses. The invention is also useful in non-articulating implant devices such as bone plates, bone screws, etc.
Patent ES-2380664-B2 (ES)
Title: Método y dispositivo para el diagnóstico rápido de enfermedades en muestras fecales.
Inventor: GENZOR ASIN CARLOS GUSTAVO
IPC: G01N33/53
Filed: 2010-10-19
Granted: 2012-09-13
Abstract: Método de diagnóstico rápido y dispositivo para llevarlo a cabo que, mediante la aplicación de una muestra de heces dispersada en un diluyente, permite la detección simultánea y diferenciada de lactoferrina y calprotectina fecales mediante la formación de conjugados con partículas coloreadas y su captura en una membrana porosa.